Literature DB >> 31999545

Antagonizing GnRH receptors: A temporary ADT salvage maneuver for prostate cancer patients experiencing PSA failure with GnRH agonist.

Jehonathan Pinthus1.   

Abstract

Entities:  

Year:  2020        PMID： 31999545      PMCID： PMC7012291          DOI： 10.5489/cuaj.6391

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  7 in total

1.  Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.

Authors:  Ian D Davis; Andrew J Martin; Martin R Stockler; Stephen Begbie; Kim N Chi; Simon Chowdhury; Xanthi Coskinas; Mark Frydenberg; Wendy E Hague; Lisa G Horvath; Anthony M Joshua; Nicola J Lawrence; Gavin Marx; John McCaffrey; Ray McDermott; Margaret McJannett; Scott A North; Francis Parnis; Wendy Parulekar; David W Pook; M Neil Reaume; Shahneen K Sandhu; Alvin Tan; T Hsiang Tan; Alastair Thomson; Emily Tu; Francisco Vera-Badillo; Scott G Williams; Sonia Yip; Alison Y Zhang; Robert R Zielinski; Christopher J Sweeney
Journal:  N Engl J Med       Date:  2019-06-02       Impact factor: 91.245

Review 2.  The gonadotropin-releasing hormone system: Perspectives from reproduction to cancer (Review).

Authors:  Arturo Aguilar-Rojas; Marco Allan Pérez-Solis; Guadalupe Maya-Núñez
Journal:  Int J Oncol       Date:  2016-01-19       Impact factor: 5.650

3.  Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.

Authors:  Stefania Mariani; Luisa Salvatori; Sabrina Basciani; Mario Arizzi; Giorgio Franco; Elisa Petrangeli; Giovanni Spera; Lucio Gnessi
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

4.  A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer.

Authors:  E David Crawford; Bertrand Tombal; Kurt Miller; Laurent Boccon-Gibod; Fritz Schröder; Neal Shore; Judd W Moul; Jens-Kristian Jensen; Tine Kold Olesen; Bo-Eric Persson
Journal:  J Urol       Date:  2011-07-23       Impact factor: 7.450

5.  Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR).

Authors:  E Ben-Josef; S Y Yang; T H Ji; J M Bidart; S V Garde; D P Chopra; A T Porter; D G Tang
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

6.  Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.

Authors:  Karim Fizazi; NamPhuong Tran; Luis Fein; Nobuaki Matsubara; Alfredo Rodriguez-Antolin; Boris Y Alekseev; Mustafa Özgüroğlu; Dingwei Ye; Susan Feyerabend; Andrew Protheroe; Peter De Porre; Thian Kheoh; Youn C Park; Mary B Todd; Kim N Chi
Journal:  N Engl J Med       Date:  2017-06-04       Impact factor: 91.245

7.  Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent manner.

Authors:  Roberta M Moretti; Marina Montagnani Marelli; Deanne M Taylor; Paolo G V Martini; Monica Marzagalli; Patrizia Limonta
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240
  7 in total
  1 in total

Review 1.  Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions.

Authors:  Fabrizio Fontana; Monica Marzagalli; Marina Montagnani Marelli; Michela Raimondi; Roberta M Moretti; Patrizia Limonta
Journal:  Int J Mol Sci       Date:  2020-12-14       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.